A new selective, reversible BTK inhibitor bearing an imidazo[4,5-b]pyridine scaffold June 9, 2021 No Comments
Brentuximab vedotin meets the primary endpoint in diffuse cutaneous systemic sclerosis study June 8, 2021 No Comments
FDA issues clinical hold letter for Ortho Regenerative Technologies' ORTHO-R June 7, 2021 No Comments
BTK-selective degrader NX-5948 reduces inflammation in a murine model of rheumatoid arthritis June 7, 2021 No Comments
Phase II results presented from study comparing AZD-9567 versus prednisolone in active RA June 3, 2021 No Comments
Safety signal halts work on AB Science’s masitinib June 1, 2021 By Richard Staines No Comments Trading in shares in AB Science SA was suspended Tuesday after a safety signal prompted a voluntary hold on two late-stage clinical studies of its masitinib, in mastocytosis and amyotrophic lateral sclerosis, respectively.Read More
RSS
